Valence8 US »

Leap Therapeutics shares owned by Valence8 US

Quarter-by-quarter ownership of Leap Therapeutics (LPTX) shares owned by Valence8 US from 13F filings

Historical chart of Valence8 US investment in Leap Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Leap Therapeutics held by Valence8 US consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Leap Therapeutics by Valence8 US

Quarter filed Position value Share count Share price at filing
2024-09-30 $48k 19k 2.57

More positions owned by Valence8 US

Ishares Tr Msci Usa Qlt Fct (QUAL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Msci Intl Qualty (IQLT)
Ishares Tr Eafe Value Etf (EFV)
Vanguard Index Fds Value Etf (VTV)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)
Ishares Tr Msci Uk Etf New (EWU)
Ishares Msci Jpn Etf New (EWJ)
Astrazeneca Sponsored Adr Call Option (AZN)
Select Sector Spdr Tr Sbi Int-utils (XLU)
Amgen Put Option (AMGN)
Soleno Therapeutics (SLNO)
Insmed Com Par $.01 Call Option (INSM)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Bristol Myers Squibb (BMY)

View all positions for Valence8 US

Top funds holding Leap Therapeutics

Balyasny Asset Management
Samsara BioCapital
683 Capital Management
Rock Springs Capital Management
Baker Bros. Advisors
Simplify Asset Management
Vanguard Group
Laurion Capital Management
Citadel Advisors
Geode Capital Management
Key Client Fiduciary Advisors
BlackRock
Acadian Asset Management
BlackRock
Dimensional Fund Advisors

View all funds holding Leap Therapeutics